310 related articles for article (PubMed ID: 21093905)
1. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice.
Liu T; Li L; Teng X; Huang X; Liu H; Chen D; Ren J; He J; Tang F
Biomaterials; 2011 Feb; 32(6):1657-68. PubMed ID: 21093905
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice.
Xie G; Sun J; Zhong G; Shi L; Zhang D
Arch Toxicol; 2010 Mar; 84(3):183-90. PubMed ID: 19936708
[TBL] [Abstract][Full Text] [Related]
3. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes.
Fu C; Liu T; Li L; Liu H; Chen D; Tang F
Biomaterials; 2013 Mar; 34(10):2565-75. PubMed ID: 23332175
[TBL] [Abstract][Full Text] [Related]
4. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
[TBL] [Abstract][Full Text] [Related]
6. Silica nanoparticles as hepatotoxicants.
Nishimori H; Kondoh M; Isoda K; Tsunoda S; Tsutsumi Y; Yagi K
Eur J Pharm Biopharm; 2009 Aug; 72(3):496-501. PubMed ID: 19232391
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility of calcined mesoporous silica particles with cellular bioenergetics in murine tissues.
Al Shamsi M; Al Samri MT; Al-Salam S; Conca W; Shaban S; Benedict S; Tariq S; Biradar AV; Penefsky HS; Asefa T; Souid AK
Chem Res Toxicol; 2010 Nov; 23(11):1796-805. PubMed ID: 20961102
[TBL] [Abstract][Full Text] [Related]
8. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation.
He Q; Zhang Z; Gao F; Li Y; Shi J
Small; 2011 Jan; 7(2):271-80. PubMed ID: 21213393
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
10. Acute toxicity and in vivo biodistribution of monodispersed mesoporous bioactive glass spheres in intravenously exposed mice.
Mao C; Chen X; Hu Q; Miao G; Lin C
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():682-91. PubMed ID: 26478360
[TBL] [Abstract][Full Text] [Related]
11. Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles.
Liu T; Li L; Fu C; Liu H; Chen D; Tang F
Biomaterials; 2012 Mar; 33(7):2399-407. PubMed ID: 22182752
[TBL] [Abstract][Full Text] [Related]
12. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles.
Cho M; Cho WS; Choi M; Kim SJ; Han BS; Kim SH; Kim HO; Sheen YY; Jeong J
Toxicol Lett; 2009 Sep; 189(3):177-83. PubMed ID: 19397964
[TBL] [Abstract][Full Text] [Related]
13. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
15. Formation of hexagonal mesoporous silica in submicrometer channels.
Kickelbick G
Small; 2005 Feb; 1(2):168-70. PubMed ID: 17193426
[No Abstract] [Full Text] [Related]
16. In vivo biodistribution and synergistic toxicity of silica nanoparticles and cadmium chloride in mice.
Guo M; Xu X; Yan X; Wang S; Gao S; Zhu S
J Hazard Mater; 2013 Sep; 260():780-8. PubMed ID: 23856307
[TBL] [Abstract][Full Text] [Related]
17. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
Fadeel B; Garcia-Bennett AE
Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.
Bimbo LM; Sarparanta M; Santos HA; Airaksinen AJ; Mäkilä E; Laaksonen T; Peltonen L; Lehto VP; Hirvonen J; Salonen J
ACS Nano; 2010 Jun; 4(6):3023-32. PubMed ID: 20509673
[TBL] [Abstract][Full Text] [Related]
19. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice.
Yang ST; Wang X; Jia G; Gu Y; Wang T; Nie H; Ge C; Wang H; Liu Y
Toxicol Lett; 2008 Oct; 181(3):182-9. PubMed ID: 18760340
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of multiwalled carbon nanotubes with end defects critically depends on their functionalization density.
Jain S; Thakare VS; Das M; Godugu C; Jain AK; Mathur R; Chuttani K; Mishra AK
Chem Res Toxicol; 2011 Nov; 24(11):2028-39. PubMed ID: 21978239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
